Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Pöttler Tina |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Hochfellner, DA; Pöttler, T; Schörghuber, M; Lukic, E; Yates, A; Keeling, I; Zimpfer, D; Elsayed, H; Aberer, F; Berti. F; Lucarelli, F; Valgimigli, F; Mader, J;
Accuracy and Safety of an Intravascular
Continuous Glucose Monitoring System
(ivCGM) in Patients on
Cardiac Surgical Intensive Care Unit – A
Pilot Study
Wien Klin Wochenschr (2024) . 2024; (136):689-724.-52. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 14–16, 2024; Salzburg, AUSTRIA.
[Poster]
FullText
Mader, JK; Baumann, PM; Cigler, M; Poettler, T; Oberosler, M; Gruber, J; Kheir, S; Harer, C; Meçani, R; Sourij, H
996-P: Correlation of GMI with HbA1c in People Living with Diabetes over Time.
Diabetes 2024;73(Supplement_1):996-P. 2024; -American Diabetes Association 84TH SCIENTIFIC SESSIONS; JUN 21-24, 2024; Orlando, FL.
[Poster]
FullText
Hochfellner, DA; Poettler, T; Schoerghuber, M; Lukic, E; Yates, A; Keeling, I;
Zimpfer, D; Roubik, L; Elsayed, H; Aberer, F; Berti, F; Lucarelli, F; Valgimigli, F; Mader, JK;
Intravenous Continuous Glucose Monitoring in Hospitalized Patients in a Critical Care Unit: Safety and Efficacy of a Novel Intravascular Continuous Glucose Monitoring System - A Pilot Trial
DIABETES TECHNOLOGY MEETING; NOV 2-4, 2023; Burlingame, California, USA;. 2023.
[Oral Communication]
Scheikl, K; Pöttler, T; Harer, CM; Schmitt, LM; Mecani, R; Mader, JK; Treiber, G
Significant increase in diabetic ketoacidosis in adults with diabetes mellitus
WIEN KLIN WOCHENSCHR. 2023; 135: S779-S779.
[Poster]
Web of Science
Baumann, P; Hochfellner, DA; Cigler, M; Roubik, L; Pottler, T; Mader, JK
Gender differences in within-day glycaemic variations in people with T1D. Insights from long-duration CGM data from a diabetes registry
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):231-232.
[Poster]
Web of Science
Baumann, PM; Hochfellner, DA; Cigler, M; Roubik, L; Pottler, T; Mader, JK
Patterns of sensor-detected hypoglycaemia in long-duration CGM data from a diabetes registry
DIABETOLOGIA. 2022; 65(SUPPL 1):S323-S323.
[Oral Communication]
Web of Science
Boughton, C; Hartnell, S; Thabit, H; Mubita, W; Draxlbauer, K; Poettler, T; Wilinska, M; Hood, K; Mader, J; Narendran, P; Leelarathna, L; Evans, M; Hovorka, R
HYBRID CLOSED-LOOP GLUCOSE CONTROL COMPARED WITH SENSOR AUGMENTED PUMP THERAPY IN OLDER ADULTS WITH TYPE 1 DIABETES: A MULTICENTRE, MULTINATIONAL, RANDOMISED, CROSSOVER STUDY
DIABETES TECHNOL THE. Abstracts from ATTD 2022. 2022; 24(S1):A54-A55.-15th International Conference on Advanced Technologies and Treatments for Diabetes; APR 27-30, 2022; Barcelona, SPAIN.
[Oral Communication]
Web of Science
Cigler, M; Baumann, P; Elsayed, H; Hochfellner, D; Pottler, T; Secco, K; Simic, A; Trajanoski, S; Groselj-Strele, A; Mader, J
Improved HbA1c is associated with better glycemic control in continuous glucose monitoring systems, but glycemic control is not influenced by treatment type or CGM duration
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):234-234.
[Poster]
Web of Science
Hochfellner, DA; Baumann, P; Reinhard, A; Pottler, T; Roubik, L; Kogler, S; Cigler, M; Treiber, G; Mader, J
Switching from isCCGM without alarms to isCCGM with alarms: what is the benefit?
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):244-244.-ÖDG Jahrestagung 2022; NOV 17-19; Salzburg, AUSTRIA.
[Poster]
Web of Science
Kastner, J; Poettler, T; Kopanz, J; Hochfellner, D; Siegl, R; Romey, M; Muchmore, D; Strasma, P; Mader, J
CURRENT INSULIN INFUSION SET CRITERIA DO NOT REPRESENT REAL-LIFE SETTING AND MAY SKEW INFUSION SET FAILURE OUTCOMES IN EXTENDED-WEAR INFUSION SET STUDIES
DIABETES TECHNOL THE. Abstracts from ATTD 2022. 2022; 24(S1):A212-A212.-15th International Conference on Advanced Technologies and Treatments for Diabetes; APR 27-30, 2022; Barcelona, SPAIN.
[Poster]
Web of Science
Mader, J; Tuca, A; Scholle, L; Pottler, T; Aberer, F; Reinhard, A; Herler, Y; Kopanz, J; Gamsey, S; Kamecke, U; Rebrin, K
The Lumee hydrogel optical glucose sensor in clinical evaluation for assessment of data processing in people with insulin-treated diabetes
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):249-250.
[Oral Communication]
Web of Science
Pottler, T; Kastner, J; Kopanz, J; Hochfellner, D; Romey, M; Muchmore, D; Strasma, P; Mader, J
Current insulin infusion set criteria do not represent real-life setting and may skew infusion set failure outcomes in extended wear infusion set studies
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):255-255.
[Oral Communication]
Web of Science
Boughton, C; Hartnell, S; Thabit, H; Poettler, T; Herzig, D; Wilinska, M; Ashcroft, N; Sibayan, J; Cohen, N; Calhoun, P; Bally, L; Mader, J; Evans, M; Leelarathna, L
REDUCTION OF HYPOGLYCAEMIA USING HYBRID CLOSED-LOOP WITH FASTER-INSULIN ASPART COMPARED WITH STANDARD-INSULIN ASPART IN ADULTS WITH TYPE 1 DIABETES: A DOUBLE-BLIND, MULTINATIONAL, RANDOMISED, CROSSOVER STUDY
DIABETES TECHNOL THE. 2021; 23: A72-A73.
[Oral Communication]
Web of Science
Bytyqi, K; Baumann, PM; Hochfellner, D; Aberer, F; Simic, A; Treiber, G; Pottler, T; Holl, B; Fahrleitner-Pammer, A; Beck, P; Mader, J
Feasibility to use a continuous glucose monitoring system to manage diabetes during hospitalisation
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):211-212.-49. Jahrestagung ÖDG; NOV 18-20; Salzburg, AUSTRIA.
[Poster]
Web of Science
Cigler, M; Elsayed, H; Ziko, H; Hochfellner, D; Kopanz, J; Pottler, T; Secco, K; Simic, A; Trajanoski, S; Groselj-Strele, A; Mader, JK
Shorter Diabetes Duration and Residual Beta Cell Function are associated with better glycemic Control as measured by continuous Glucose Monitoring in People with Type 1 Diabetes
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):212-212.
[Oral Communication]
Web of Science
Groselj-Strele, A; Elsayed, H; Cigler, M; Ziko, H; Hochfellner, DA; Kopanz, J; Pottler, T; Secco, K; Simic, A; Trajanoski, S; Mader, JK
Influence of Seasons on glycemic Control as measured with CGM Metrics in People with Type 1 Diabetes
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):219-219.
[Oral Communication]
Web of Science
Hochfellner, DA; Baumann, PM; Aberer, F; Simic, A; Bytyqi, L; Pottler, T; Holl, B; Fahrleitner-Pammer, A; Pieber, TR; Beck, P; Mader, J
Basal-bolus Insulin Therapy through an electronic Decision Support System for stationary glycemic Control with Insulin degludec
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):209-209.
[Poster]
Web of Science
Mader, J; Simic, A; Roosen, M; Hartmann, M; Scholle, L; Siegl, R; Vardanyan, S; Pottler, T; Menzie, W; Gamsey, S; Rebrin, K; Kamecke, U
GLUCOSE TRACKING WITH OPTICAL MEASUREMENT IN CLINICAL EVALUATION-PROFUSA LUMEE GLUCOSE PLATFORM
DIABETES TECHNOL THE. 2021; 23: A37-A38.
[Oral Communication]
Web of Science
Pottler, T; Etter, T; Kaestel, H; Schutz-Fuhrmann, I; Stechemesser, L; Dagenbach, N; Ebenbichler, C; Vonbank, A; Weitgasser, R; Mader, J
Comparison of Treatment Satisfaction with Pen-based Therapy versus the Accu-Chek (R) Solo and mylifeTM OmniPod (R) Insulin Pumps among pump-naive People with Type 1 Diabetes in Austria
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):225-226.
[Oral Communication]
Web of Science
Secco, K; Ziko, H; Pottler, T; Hochfellner, D; Weitgasser, R; Schutz-Fuhrmann, I; Mader, JK
Glycemic control in type 1 diabetes during COVID-19 pandemic
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):220-220.
[Keynote lecture]
Web of Science
Simic, A; Taucher, M; Hochfellner, D; Pottler, T; Aberer, F; Mader, J
Glucomen Day (R) CGM system accuracy assessment in individuals with type 1 diabetes
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):200-200.
[Poster]
Web of Science
Aberer, F; Hochfellner, D; Ziko, H; Sagmeister, MH; Cigler, M; Simic, A; Pottler, T; Sendlhofer, G; Beck, P; Mader, JK
Efficiency and Safety of an electronic Decision Support System for Insulin Therapy in hospitalized Female Patients with Type 2 Diabetes.
WIEN KLIN WOCHENSCHR. 2020; 132: S334-S334.
[Poster]
Web of Science
Cigler, M; Ziko, H; Elsayed, H; Hochfellner, D; Pottler, T; Muller, A; Eckstein, ML; Knoll, L; Sourij, H; Mader, JK; Moser, O
People with type 1 diabetes and impaired awareness of hypoglycaemia have a delayed reaction to perform a glucose scan during hypoglycaemia: a prospective observational study.
DIABETOLOGIA. 2020; 63(SUPPL 1):S359-S359.-56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 21-25, 2020; virtuell.
[Poster]
Web of Science
Eckstein, M; Ziko, H; Moser, O; Elsayed, H; Cigler, M; Hochfellner, D; Pottler, T; Mueller, A; Sourij, H; Mader, J
DISCREPANCY OF GLYCAEMIC RANGES IN REGARD TO CGM METRICS FOR CLINICAL CARE VERSUS GUIDANCE FOR GLYCAEMIC TARGETS WITHIN THE RECENT CONSENSUS ON TIR.
DIABETES TECHNOL THE. 2020; 22: A106-A106.
[Poster]
Web of Science
Fischer, LT; Aberer, F; Hochfellner, D; Knoll, L; Pottler, T; Mader, JK
Prescribing Indications and metabolic Effects of PCSK9-Inhibitors in a tertiary Center - A retrospective Study.
WIEN KLIN WOCHENSCHR. 2020; 132: S349-S349.-ÖDG ;
[Poster]
Web of Science
Haberl, HC; Pottler, T; Hochfellner, D; Aberer, F; Ziko, H; Simic, A; Bytyqi, L; Baumann, P; Samonigg, J; Beck, P; Fahrleitner-Pammer, A; Mader, JK
Evaluation of the Sensor Performance of a blinded, professional continuous Glucose Measurement System in hospitalized Female Patients with Type 2 Diabetes.
WIEN KLIN WOCHENSCHR. 2020; 132: S360-S360.-Jahrestagung der österreichischen Diabetesgesellschaft ;
[Poster]
Web of Science
Haberl, HC; Pottler, T; Hochfellner, DA; Aberer, F; Ziko, H; Bytyqi, L; Baumann, P; Samonigg, J; Beck, P; Fahrleitner-Pammer, A; Mader, JK
Assessment of sensor performance of a blinded professional continuous glucose monitoring system in hospitalised patients with type 2 diabetes.
DIABETOLOGIA. 2020; 63(SUPPL 1):S348-S349.-56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 21-25, 2020; ELECTR NETWORK.
[Poster]
Web of Science
Hochfellner, D; Schondorff, P; Stumpe, T; Heschel, M; Pottler, T; Elsayed, H; Simic, A; Bytyqi, K; Augustin, T; Lueger, A; Mader, J
COMPARISON OF INFUSION SET SURVIVAL OF THE NEWLY DEVELOPED ARTIFICIALLY CLOGGED LANTERN CATHETER VS. STANDARD INFUSION SET IN TYPE 1 DIABETES UNDER REAL-LIFE CONDITIONS.
DIABETES TECHNOL THE. The Official Journal of ATTD: Advanced Technologies & Treatments for Diabetes Conference. 2020; 22: A240-A241.-Advanced Technologies & Treatments for Diabetes Conference; FEB 19-20, 2020; Madrid, SPAIN.
[Poster]
Web of Science
Hochfellner, D; Ziko, H; Elsayed, H; Cigler, M; Knoll, L; Pöttler, T; Aberer, F; Mader, J
Glucose scan behaviour in people with type 1 diabetes using flash glucose monitoring in a real-world setting.
ENDOCRINE ABSTRACTS. 2020; 70(AEP458):-22nd European Congress of Endocrinology, European Society of Endocrinology (ESE); SEP 5-9, 2020 ; Bristol, UK.
[Poster]
FullText
Hochfellner, D; Ziko, H; Elsayed, H; Cigler, M; Knoll, L; Pottler, T; Treiber, G; Simic, A; Aberer, F; Mader, J
Scan-Behavior in People with Type-1-Diabetes and Flash-Glucose-Monitoring in a Real-World-Setting.
WIEN KLIN WOCHENSCHR. Abstracts 51.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin. 2020; 132(SUPPL 2):76-76.-51.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 24-26, 2020; Salzburg, AUSTRIA.
[Onlinepräsentation]
Web of Science
Hochfellner, DA; Ziko, H; Elsayed, H; Cigler, M; Knoll, L; Pöttler, T; Aberer, F; Mader, JK
“White Coat Adherence” bei Menschen mit Typ 1 Diabetes und Flash Glucose Monitoring im klinischen Alltag.
25. Jahrestagung der Österreichischen Gesellschaft für Endokrinologie und Stoffwechsel (ÖGES) gemeinsam mit der Austrian Neuroendocrine Tumor Society (ANETS). J. Klin. Endokrinol. Stoffw. . 2020; 13(1):5-15.-25. Jahrestagung der Österreichischen Gesellschaft für Endokrinologie und Stoffwechsel (ÖGES) gemeinsam mit der Austrian Neuroendocrine Tumor Society (ANETS); APR 15–17, 2020; Graz, AUSTRIA.
[Poster]
FullText
Hochfellner, DA; Ziko, H; Sagmeister, MH; Elsayed, H; Cigler, M; Poettler, T; Aberer, F; Sendlhofer, G; Beck, P; Mader, JK
Electronic Decision Support for Insulin Therapy Is Safe and Efficient in Inpatients with Type 2 Diabetes.
DIABETES. 2020; 69(S 1):-80th Scientific Sessions American Diabetes Association (ADA); JUN 12-16,2020; Chicago, IL, USA;.
Doi: 10.2337/db20-24-OR
[Oral Communication]
Web of Science
FullText
FullText_MUG
Moser, O; Ziko, H; Eckstein, M; Elsayed, H; Cigler, M; Hochfellner, D; Poettler, T; Mueller, A; Sourij, H; Mader, J
TIME IN RANGE (TIR) ACHIEVEMENT IN REGARD TO CLINICAL TARGETS IN PEOPLE WITH TYPE 1 DIABETES (PWT1D): A REAL WORLD SETTING.
DIABETES TECHNOL THE. The Official Journal of ATTD: Advanced Technologies & Treatments for Diabetes Conference. 2020; 22: A231-A231.-Advanced Technologies & Treatments for Diabetes Conference; FEB 19-20, 2020; Madrid, SPAIN.
[Poster]
Web of Science
Moser, O; Ziko, H; Elsayed, H; Hochfellner, D; Pottler, T; Muller, A; Eckstein, M; Sourij, H; Mader, JK
The FreeStyle Libre 1 isCGM System as the first objective Measuring Instrument for the Diagnosis of Hypoglycemia Unawareness in People with Type 1 Diabetes - A prospective Observational Study.
WIEN KLIN WOCHENSCHR. 2020; 132: S343-S344.
[Poster]
Web of Science
Moser, O; Ziko, H; Elsayed, H; Hochfellner, DA; Poettler, T; Mueller, A; Eckstein, ML; Knoll, L; Sourij, H; Mader, JK
People with Type 1 Diabetes and Impaired Awareness of Hypoglycemia Have a Delayed Reaction to Perform a Glucose Scan during Hypoglycemia: A Prospective Observational Study.
DIABETES. 2020; 69: -80th Scientific Sessions of the American-Diabetes-Association (ADA); JUN 12-16, 2020; ELECTR NETWORK.
Doi: 10.2337/db20-157-OR
[Onlinepräsentation]
Web of Science
FullText
FullText_MUG
Simic, A; Ziko, H; Pottler, T; Hochfellner, D; Samonigg, J; Cigler, M; Beck, P; Aberer, F; Mader, JK
A retrospective assessment of blinded continuous glucose monitor accuracy during inpatient management of adults with type 2 diabetes.
WIEN KLIN WOCHENSCHR. 2020; 132: S363-S363.
[Poster]
Web of Science
Elsayed, H; Bytyqi, K; Simic, A; Cigler, M; Hochfellner, D; Ziko, H; Knoll, L; Pottler, T; Aberer, F; Mader, J
Influence of C-Peptide Status on Frequency and Mean Duration of Hypoglycemia, Time in Blood Sugar Target Range and HbA1c in Type 1 Diabetics using Flash Glucose Monitoring in clinical Routine
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S471-S471.
[Oral Communication]
Web of Science
Hochfellner, DA; Ziko, H; Elsayed, H; Simic, A; Cigler, M; Knoll, L; Pottler, T; Aberer, F; Mader, J
Flash Glucose Monitoring in Routine Clinical Use in Patients with Type 1 Diabetes
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S470-S470.
[Poster]
Web of Science
Simic, A; Elsayed, H; Ziko, H; Hochfellner, D; Cigler, M; Knoll, L; Pottler, T; Aberer, F; Mader, JK
The effect of glucose scanning frequency on HbA1c in individuals with type 1 diabetes using FGM
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S482-S482.
[Keynote lecture]
Web of Science
Ziko, H; Hochfellner, D; Elsayed, H; Simic, A; Cigler, M; Knoll, L; Pottler, T; Aberer, F; Mader, JK
Influence of Flash Glucose Monitoring on Glycemic Target Achievement
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S487-S487.
[Poster]
Web of Science
Ajsic, A; Krasser, MC; Juliussen, R; Schøndorff, PK; Heschel, M; Pöttler, T;
Schwarzenbacher, D; Augustin, T; Pieber, TR; Treiber, G; Mader, JK
Assessment of Infusion Set Survival of the Newly Developed
Lantern Catheter in Type 1 Diabetes by Glucose Clamp Technique.
Diabetes. 2018; 67(S1):-78th Scientific Sessions of the American Diabetes Association (ADA); JUN 22-26, 2018; Orlando, USA.
[Poster]
FullText
Ajsic, A; Krasser, MC; Juliussen, R; Schondorff, PK; Heschel, M; Pottler, T; Schwarzenbacher, D; Augustin, T; Pieber, TR; Treiber; Mader, JK
Examination of a prolonged Wearing Period of the newly developed Insulin Infusion Lantern Catheter in Patients with Type 1 Diabetes mellitus
WIEN KLIN WOCHENSCHR. 2018; 130: 360-360.
[Poster]
Web of Science
Cigler, M; Pandis, M; Juliussen, R; Schondorff, PK; Heschel, M; Pottler, T; Augustin, T; Schwarzenbacher, D; Pieber, RT; Treiber, G; Mader, JK
ASSESSMENT OF INFUSION SET SURVIVAL OF THE NEWLY DEVELOPED LANTERN CATHETER IN TYPE 1 DIABETES BY GLUCOSE CLAMP TECHNIQUE (A PILOT STUDY)
DIABETES TECHNOL THE. 2018; 20: A126-A127.
[Poster]
Web of Science
Drechsler, K; Pottler, T; Elsayed, H; Kiesling, L; Aberer, F; Mader, J
A Questionnaire Survey on treatment-associated Errors from the Perspective of Patients with Type 2 Diabetes in an internistic Normal Ward
WIEN KLIN WOCHENSCHR. 2018; 130: 365-365.
[Poster]
Web of Science
Drechsler, KS; Pöttler, T; Elsayed, H; Kiesling, L; Aberer, F;
Mader, JK
Eine Fragebogenerhebung zu therapieassoziierten Fehlern aus der Sicht von PatientInnen mit Typ 2 Diabetes auf einer internistischen Normalstation
Wien Klin Wochenschr. 2018; 130(Suppl 6): 343-374.-46. Jahrestagung der österreichischen Diabetesgesellschaft (ÖDG) ; NOV 15-17, 2018; Salzburg, AUSTRIA.
[Poster]
Kojzar, H; Frohlich-Reiterer, E; Mader, JK; Pottler, T; Elsayed, H; Jasser-Nitsche, H; Rami-Merhar, B; Fritsch, M; Nagl, K; Hofer, S; Abt, D; Binder, E; Streichen, E; Acerini, CL; de Beaufort, C; Campbell, F; Kapellen, T; Lawton, J; Roze, S; Sibayan, J; Sonesson, A; Allen, J; Tauschmann, M; Musolino, G; Barber, N; Wilinska, ME; Hovorka, R
Use of the artificial Pancreas in Infants with Diabetes mellitus Type 1 KidsAP01
WIEN KLIN WOCHENSCHR. 2018; 130: 347-348.
[Oral Communication]
Web of Science
Mader, JK; Ajsic, A; Krasser, MC; Juliussen, R; Schondorff, PK; Heschel, M; Pottler, T; Schwarzenbacher, D; Augustin, T; Pieber, TR; Treiber, G
Assessment of infusion set survival of the newly developed coated Lantern catheter in type 1 diabetes by glucose clamp technique
DIABETOLOGIA. 2018; 61: S395-S395.-54th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); OCT 01-05, 2018; Berlin, GERMANY.
[Poster]
Web of Science
Aberer, F; Poettler, T; Sourij, H; Tripolt, NJ; Becvar, S; Leitgeb, S; Pieber, TR; Novak, E; Mader, JK
Insulin Pump Therapy in Patients with Diabetes Mellitus Type 2: A Survey of Patient Expectations.
Diabetes. 2017; 66(S1):A622-A622.-77th Scientific Sessions of the American Diabetes Association (ADA); JUN 9-13, 2017; San Diego, CA, USA.
Mader, JK; Aberer, F; Pöttler, T; Novak, E; Warner, J; Trautmann, M; Pieber, TR
PAQ, ein einfaches Insulinabgabegerät für Basis-Bolus-Therapie, erhöht die Zeit im Blutzuckerzielbereich signifikant.
Diabetologie und Stoffwechsel. 2017; 12(S1):S53-S53.-Diabetes Kongress 2017; MAY 24-27, 2017; Hamburg, GERMANY.
[Poster]
Mader, JK; Aberer, F; Pöttler, T; Novak, E; Warner, J; Trautmann, M; Pieber, TR
PAQ - ein einfaches Insulinabgabegerät für Basis-Bolus-Therapie erhöht die Zeit im Blutzuckerzielbereich signifikant.
J Klin Endokrinol Stoffw. 2017; 10(S1):6-7.-Joint Annual Meeting of the ÖGES (Österreichische Gesellschaft für Endokrinologie und Stoffwechsel) and the OSDG (Österreichische Schilddrüsengesellschaft); MAR 22-24, 2017; Linz, AUSTRIA.
[Oral Communication]
Mader, JK; Hermanns, N; Lilly, L; Aberer, F; Poettler, T;
Lanz, C; Warner, J; Pieber, T
PAQ Insulin delivery device improves glycemic control and diabetes
treatment satisfaction in adults wit type 2 diabetes.
Diabetes Technology & Therapeutics. 2017; 19(S01):A-119-A-119.-10th International Conference of Advanced Technologies and Treatments for Diabetes (ATTD); FEB 15-18, 2017; Paris, FRANCE.
[Poster]
Mader, JK; Lilly, LC; Aberer, F; Poettler, T; Novak, E; Lanz, C; Trautmann, ME; Warner, J; Pieber, TR
PAQ, 3-Month Treatment in Adults with Type 2 Diabetes.
Diabetes. 2017; 66(S1):A277-A277.-77th Scientific Sessions of the American Diabetes Association (ADA); JUN 9-13, 2017; San Diego, CA, USA.
[Poster]
Pöttler, T; Lilly, LC; Aberer, F; Novak, E; Lanz, C; Trautmann, ME; Warner, J; Pieber, TR; Mader, JK
3 month treatment with a simple 3-day insulin delivery device in adults with type 2 diabetes.
International Diabetes Federation (IDF) Congress; DEC 4-8, 2017; Abu Dhabi, UNITED ARAB EMIRATES. 2017.
[Poster]
Pottler, T; Lilly, LC; Aberer, F; Trautmann, M; Warner, J; Pieber, TR; Mader, JK
Results of three Months of Insulin Therapy with PAQ((R)) in Female Patients with Type 2 Diabetes
WIEN KLIN WOCHENSCHR. 2017; 129: 173-173.
[Poster]
Web of Science
Pöttler, T; Lilly, LC; Aberer, F; Trautmann, M; Warner, J; Pieber, TR; Mader, JK
Ergebnisse von drei Monaten Insulintherapie mit PAQ bei PatientInnen mit Typ 2 Diabetes
Wiener klinische Wochenschrift, Ausgabe 129 (Suppl. 4) . 2017; 173-173.-45. Jahrestagung der Österreichischen Diabetesgesellschaft (ÖDG); NOV 16-18; Salzburg.
[Oral Communication]
Mader, JK; Lilly, LC; Aberer, F; Poettler, T; Becvar, S; Lanz, C; Trautmann, M; Pieber, TR
PAQ® 3-Month Observation Study in Adults with Type 2 Diabetes.
Diabetes. 2016; 65(S1):A262-A262.-76th Scientific Sessions of the American Diabetes Association (ADA); JUN 10-14, 2016; New Orleans, LA, USA.
[Poster]
Mader, JK; Lilly, LC; Aberer, F; Poettler, T; Becvar, S; Lanz, C; Trautmann, M; Pieber, TR
PAQ®, A Simple 3-Day Basal/Bolus Insulin Delivery Device for People with Type 2 Diabetes.
DIABETES TECHNOL THE. 2016; 18: A109-A109.-9th International Conference of Advanced Technologies and Treatments for Diabetes (ATTD) ; FEB 3-6, 2016; Milan, ITALY.
[Poster]
Web of Science
Mader, JK; Lilly, LC; Aberer, F; Pottler, T; Becvar, S; Lanz, C; Trautmann, M; Pieber, TR
Application of PAQ®, an Insulin Dosage Device for Patients with Type 2 Diabetes mellitus, for 3 Months
WIEN KLIN WOCHENSCHR. Wiener Klinische Wochenschrift. 2016; 128(Supp 6):S399-S400.-44. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 17-19, 2016; Salzburg, AUSTRIA.
[Oral Communication]
Web of Science
Mader, JK; Lilly, LC; Aberer, F; Pöttler, T; Becvar, S; Lanz, C; Trautmann, M; Pieber, TR
PAQ® - 3 Month Observation Study in Adults with Type 2 Diabetes.
16th Annual Diabetes Technology Meeting (DTM); NOV 10-12, 2016; Bethesda, MD, USA. 2016.
[Poster]
Aberer, F; Lilly, LC; Pöttler, T; Becvar, S; Lanz, C; Novak, E; Trautmann, M; Pieber, TR; Mader, JK
Überprüfung der Effizienz und Sicherheit eines einfachen Insulinabgabegerätes (PaQ) bei Patienten mit Diabetes mellitus Typ 2.
Wiener Klinische Wochenschrift. 2015; 127(Supp 4):S136-S136.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 19-21, 2015; Salzburg, AUSTRIA.
[Poster]
Web of Science
Leitgeb, S; Ribitsch, A; Pöttler, T; Novak, E; Mader, J; Pieber, T; Treiber, G;
Geschlechtsspezifische Unterschiede diabetischer Spätkomplikationen bei übergewichtigen und adipösen Patienten mit Diabetes Typ 1
Diabetologie und Stoffwechsel 2015. 2015; 10(S 01):S10-S10.-50. Diabetes Kongress der Deutschen Diabetes Gesellschaft ; MAI 13-16, 2015; Berlin, GERMANY.
[Poster]
Mader, JK; Lilly, L; Aberer, F; Poettler, T; Trautmann, M; Pieber, T
PAQ, A SIMPLE 3-DAY INSULIN DELIVERY DEVICE, IMPROVES GLYCEMIC CONTROL
DIABETES TECHNOL THE. 2015; 17: A13-A13.
[Oral Communication]
Web of Science
Mader, JK; Lilly, LC; Aberer, F; Pöttler, T; Lanz, C; Trautmann, M; Pieber, TR
PaQ®, ein einfaches Insulindosierungsgerät für Basis-Bolus-Therapie bei Patientinnen mit Typ 2 Diabetes, verbessert die Blutzuckereinstellung.
Diabetologie und Stoffwechsel. 2015; 10(S 01):S86-S86.-50. Diabetes Kongress der Deutschen Diabetes Gesellschaft (DDG); MAY 13-16, 2015; Berlin, GERMANY.
[Poster]
Mader, JK; Lilly, LC; Aberer, F; Pöttler, T; Trautmann, M; Pieber, TR
A Study to Assess the Performance of PaQ®, a Simple 3-Day Basal Bolus Insulin Delivery Device after 12 Weeks of Treatment in People with Type 2 Diabetes.
Diabetes. 2015; 64(S1):A272-A272.-75th Scientific Sessions of the American Diabetes Association (ADA); JUN 5-9, 2015; Boston, USA.
[Poster]